Neutralizing the MERS Coronavirus Threat

Bart Haagmans, Ab Osterhaus

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Original languageUndefined/Unknown
JournalScience Translational Medicine
Volume6
Issue number235
DOIs
Publication statusPublished - 2014

Cite this